We are pleased to announce the launch of the General Incorporated Association Cancer Treatment Creation Organization, the preparation of which has taken considerable time.
We will actively introduce spatial transcriptomics, advanced AI, and quantum computer technology, which are necessary for the future exploration of new drug discovery targets and the development of drug discovery technologies from a global perspective, and promote the development of pharmaceutical products and personalized treatment as well as the creation of global evidence from Japan. In addition, we will encourage the invitation of overseas emerging biopharma (EBP) companies contributing to drug loss and the cultivation of domestic EBP.